BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 35700727)

  • 1. Rational exploration of fold atlas for human solute carrier proteins.
    Xie T; Chi X; Huang B; Ye F; Zhou Q; Huang J
    Structure; 2022 Sep; 30(9):1321-1330.e5. PubMed ID: 35700727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural biology of solute carrier (SLC) membrane transport proteins.
    Bai X; Moraes TF; Reithmeier RAF
    Mol Membr Biol; 2017; 34(1-2):1-32. PubMed ID: 29651895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of a novel microscale thermophoresis ligand-binding assay for characterization of SLC solute carriers using oligopeptide transporter PepT1 (SLC15 family) as a model system.
    Clémençon B; Lüscher BP; Hediger MA
    J Pharmacol Toxicol Methods; 2018; 92():67-76. PubMed ID: 29580877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transporter-Mediated Drug Delivery.
    Gyimesi G; Hediger MA
    Molecules; 2023 Jan; 28(3):. PubMed ID: 36770817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic in silico discovery of novel solute carrier-like proteins from proteomes.
    Gyimesi G; Hediger MA
    PLoS One; 2022; 17(7):e0271062. PubMed ID: 35901096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A guide to plasma membrane solute carrier proteins.
    Pizzagalli MD; Bensimon A; Superti-Furga G
    FEBS J; 2021 May; 288(9):2784-2835. PubMed ID: 32810346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The solute carrier families have a remarkably long evolutionary history with the majority of the human families present before divergence of Bilaterian species.
    Höglund PJ; Nordström KJ; Schiöth HB; Fredriksson R
    Mol Biol Evol; 2011 Apr; 28(4):1531-41. PubMed ID: 21186191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiating SLC transporter activity: Emerging drug discovery opportunities.
    Rives ML; Javitch JA; Wickenden AD
    Biochem Pharmacol; 2017 Jul; 135():1-11. PubMed ID: 28214518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Solute Carrier Transporters in Glioma Pathology: A Comprehensive Review.
    Anagnostakis F; Kokkorakis M; Markouli M; Piperi C
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phylogenetic analysis between humans and D. melanogaster: A repertoire of solute carriers in humans and flies.
    Ceder MM; Fredriksson R
    Gene; 2022 Jan; 809():146033. PubMed ID: 34673204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The genetic landscape of the human solute carrier (SLC) transporter superfamily.
    Schaller L; Lauschke VM
    Hum Genet; 2019 Dec; 138(11-12):1359-1377. PubMed ID: 31679053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probable role for major facilitator superfamily domain containing 6 (MFSD6) in the brain during variable energy consumption.
    Bagchi S; Perland E; Hosseini K; Lundgren J; Al-Walai N; Kheder S; Fredriksson R
    Int J Neurosci; 2020 May; 130(5):476-489. PubMed ID: 31906755
    [No Abstract]   [Full Text] [Related]  

  • 13. Advances and Challenges in Rational Drug Design for SLCs.
    Garibsingh RA; Schlessinger A
    Trends Pharmacol Sci; 2019 Oct; 40(10):790-800. PubMed ID: 31519459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression analysis of human solute carrier (SLC) family transporters in nasal mucosa and RPMI 2650 cells.
    Dolberg AM; Reichl S
    Eur J Pharm Sci; 2018 Oct; 123():277-294. PubMed ID: 30041030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Druggability of Solute Carriers.
    Wang WW; Gallo L; Jadhav A; Hawkins R; Parker CG
    J Med Chem; 2020 Apr; 63(8):3834-3867. PubMed ID: 31774679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting SLC transporters: small molecules as modulators and therapeutic opportunities.
    Schlessinger A; Zatorski N; Hutchinson K; Colas C
    Trends Biochem Sci; 2023 Sep; 48(9):801-814. PubMed ID: 37355450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Identification and Evolutionary Trends of the Solute Carrier Superfamily in Arthropods.
    Denecke SM; Driva O; Luong HNB; Ioannidis P; Linka M; Nauen R; Geibel S; Vontas J
    Genome Biol Evol; 2020 Aug; 12(8):1429-1439. PubMed ID: 32681801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solute Carrier Transporters as Potential Targets for the Treatment of Metabolic Disease.
    Schumann T; König J; Henke C; Willmes DM; Bornstein SR; Jordan J; Fromm MF; Birkenfeld AL
    Pharmacol Rev; 2020 Jan; 72(1):343-379. PubMed ID: 31882442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane transporters in cell physiology, cancer metabolism and drug response.
    Alam S; Doherty E; Ortega-Prieto P; Arizanova J; Fets L
    Dis Model Mech; 2023 Nov; 16(11):. PubMed ID: 38037877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long evolutionary conservation and considerable tissue specificity of several atypical solute carrier transporters.
    Sreedharan S; Stephansson O; Schiöth HB; Fredriksson R
    Gene; 2011 Jun; 478(1-2):11-8. PubMed ID: 21044875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.